Stay updated with breaking news from Trial Identifier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALO ALTO, Calif., May 10, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developi...
Hollywood, Fla (PRWEB) May 04, 2022 -- Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial septal defects
CGuard Carotid Stent will now be a treatment option in the stenting plus medical therapy arm of the trial for patients
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...